MedPath

A clinical study on siddha trial drug saaranai ennai (int&ext)in children having Balakarapan (atopic dermatitis)

Phase 2
Conditions
Health Condition 1: L20-L30- Dermatitis and eczema
Registration Number
CTRI/2018/08/015416
Lead Sponsor
Government siddha medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Itching

Erythema

Hyperpigmentation

Lichenification

Oozing

Vesicles

Exclusion Criteria

Scabies

Photo dermatitis

Psoriasis

Frunculosis

Secondary bacterial infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in EASI score(Eczema area severity index) <br/ ><br>Reduction in clinical symptoms like Itching oozing Lichenification <br/ ><br>Photos of the patient before and after treatment for the evidence clinical improvementTimepoint: Nil
Secondary Outcome Measures
NameTimeMethod
It is assessed by comparing the safety parameters before and after treatmentTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath